Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only
Recalled by Annora Pharma Private Limited
Class III — least serious
Using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
Annora Pharma Private Limited has recalled Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on March 25, 2026 and was initiated on February 3, 2026. It is classified as a Class III recall, which means using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, with approximately 770 bottles affected. The company behind the recall is Annora Pharma Private Limited, based in Hyderabad, N/A. The FDA describes the product as: “Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141, Manufactured by: Annora Pharma Pvt. LTd., Sengareddy - 502313, Telengana, India, NDC 72603-479-01.”
Why was Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only recalled?
According to the FDA, the stated reason for the recall is: “Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg.”
What should you do?
If you think you may have bought Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only, compare it against the product description and identifying codes (Lot #: A252487, Exp 05/31/2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Annora Pharma Private Limited or your local health authority.
About this recall
This recall was distributed in N/A. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- March 25, 2026
- Recall started
- February 3, 2026
- Distributed in
- N/A
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only recalled?+
According to the FDA: Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin…
How serious is this recall?+
Class III — least serious. Using this product is not likely to cause health problems, but it breaks an FDA rule (for example, a labeling or packaging issue).
What should I do if I have Pitavastatin Tablets, 2 mg, packaged in 90-count bottles, Rx only?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0391-2026. Information last synced from the FDA on July 5, 2026.